MiniMed Completes Separation From Medtronic

MiniMed has completed its separation from Medtronic plc, marking its first day as a fully independent company, according to Investing News Network.

Investing News Network reported that MiniMed announced the completed separation and identified the event as a significant milestone. Medtronic separately announced completion of its separation of MiniMed Group, Inc.

MiniMed Begins as an Independent Company

According to Investing News Network, MiniMed is now fully independent following the completion of its separation from Medtronic. The announcement identifies MiniMed as Nasdaq-listed under the symbol MMED.

Medtronic is identified in the announcement as NYSE-listed under the symbol MDT. The two announcements describe the same completed separation involving MiniMed Group, Inc.

The event establishes MiniMed and Medtronic as separate companies following their prior relationship. MiniMed’s announcement focused on the completion of the separation and its first day as an independent company.

Medtronic Confirms Completion

Medtronic also confirmed that the separation of MiniMed Group, Inc. had been completed, Investing News Network reported. In its announcement, Medtronic referenced what MiniMed and Medtronic accomplished together and the difference made in the lives of people with diabetes.

For medical-device sales professionals tracking diabetes-focused organizations, the announcements provide a formal update on the companies’ corporate structure. The reports identify MiniMed as MMED on Nasdaq and Medtronic as MDT on the NYSE.

Reported Details

• MiniMed completed its separation from Medtronic.
• MiniMed began its first day as a fully independent company.
• Medtronic announced completion of the separation of MiniMed Group, Inc.
• MiniMed is identified as Nasdaq: MMED.
• Medtronic is identified as NYSE: MDT.

Both announcements were reported by Investing News Network.